Effect of systemically administered caerulein on dopamine metabolism in rat brain
- 17 December 1984
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 324 (1) , 195-199
- https://doi.org/10.1016/0006-8993(84)90643-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophreniaLife Sciences, 1983
- Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the ratNeuroscience Letters, 1983
- Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesionsLife Sciences, 1983
- Tolerance to the anti-avoidance properties of cholecystokinin-octapeptidePeptides, 1983
- Modulation of [3H]-dopamine binding by cholecystokinin octapeptide (CCK-8)Peptides, 1982
- Origin of the Cholecystokinin-Containing Fibers in the Rat CaudatoputamenScience, 1982
- Influence of cholecystokinin octapeptide sulfate ester on brain monoamine metabolism in ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidolNeuropharmacology, 1981
- Evidence for coexistence of dopamine and CCK in meso-limbic neuronesNature, 1980
- Inhibition of dopamine‐sensitive adenylate cyclase in rat striatum by neuroleptic drugs administered in vivoJournal of Neurochemistry, 1978